Prosperity Consulting Group’s CVS Health CVS Stock Holding History

Prosperity Consulting Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,145	Closed	-$213K	–	458
2025 Q1	$213K	Buy	+3,145	New	+$188K	0.02%	435
2024 Q4	–	Sell	-3,193	Closed	-$201K	–	467
2024 Q3	$201K	Sell	3,193 -341	-10%	-$19.9K	0.02%	448
2024 Q2	$209K	Sell	3,534 -797	-18%	-$49.9K	0.03%	292
2024 Q1	$345K	Buy	4,331 +638	+17%	+$48.7K	0.04%	259
2023 Q4	$292K	Buy	3,693 +479	+15%	+$34.1K	0.1%	160
2023 Q3	$224K	Buy	+3,214	New	+$228K	0.1%	131
2022 Q1	–	Sell	-1,877	Closed	-$204K	–	96
2021 Q4	$204K	Buy	+1,877	New	+$173K	0.15%	94

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prosperity Consulting Group's CVS Position: Q2 2025 in Review

Prosperity Consulting Group sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,145 shares — an estimated $213K sold.

Prosperity Consulting Group first reported a position in CVS in Q4 2021 and held it in 7 quarters. The position peaked at $345K in Q1 2024. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Prosperity Consulting Group reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Prosperity Consulting Group sold 3,145 CVS Health shares in Q2 2025, an estimated $213K.
Prosperity Consulting Group first reported a position in CVS Health in Q4 2021 and held it in 7 quarters.
Prosperity Consulting Group's CVS Health position peaked at $345K in Q1 2024.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Prosperity Consulting Group's 13F filing for Q2 2025, filed 5 Aug 2025.